Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

European society of contraception statement on contraception in obese women

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hepatotoxicity induced by a second-generation combined oral contraceptive: case report and review of the literature

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sexual and reproductive health and HIV in border districts affected by migration and poverty in Tanzania

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Effekt af behandling med liraglutid på kardiovaskulære biomarkører hos kvinder med PCOS

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  2. Within-day energy deficiency and reproductive function in female endurance athletes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Gabriele S Merki-Feld
  • Sven Skouby
  • David Serfaty
  • Medard Lech
  • Johannes Bitzer
  • Pier Giorgio Crosignani
  • Angelo Cagnacci
  • Regine Sitruk-Ware
Vis graf over relationer

Abstract The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

OriginalsprogEngelsk
TidsskriftThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Vol/bind20
Udgave nummer1
Sider (fra-til)19-28
Antal sider10
ISSN1362-5187
DOI
StatusUdgivet - feb. 2015

ID: 44938379